

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 6.75844639 |
| 2 | regulation of metalloenzyme activity (GO:0048552) | 5.98854703 |
| 3 | adenosine receptor signaling pathway (GO:0001973) | 5.95678889 |
| 4 | angiogenesis involved in wound healing (GO:0060055) | 5.77873467 |
| 5 | membrane raft organization (GO:0031579) | 5.57946185 |
| 6 | thrombin receptor signaling pathway (GO:0070493) | 5.23557448 |
| 7 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 4.94542680 |
| 8 | heart trabecula formation (GO:0060347) | 4.78253332 |
| 9 | cardiac myofibril assembly (GO:0055003) | 4.76768307 |
| 10 | sarcomere organization (GO:0045214) | 4.64722892 |
| 11 | substrate-dependent cell migration (GO:0006929) | 4.60439887 |
| 12 | negative regulation of monooxygenase activity (GO:0032769) | 4.36346366 |
| 13 | positive regulation of odontogenesis (GO:0042482) | 4.35660052 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 4.30535722 |
| 15 | regulation of the force of heart contraction (GO:0002026) | 4.27712836 |
| 16 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.25313043 |
| 17 | myofibril assembly (GO:0030239) | 4.16917565 |
| 18 | positive regulation of protein kinase C signaling (GO:0090037) | 4.11330194 |
| 19 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 4.08280178 |
| 20 | megakaryocyte development (GO:0035855) | 3.93735940 |
| 21 | mannose metabolic process (GO:0006013) | 3.89738280 |
| 22 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.87643297 |
| 23 | regulation of actin filament-based movement (GO:1903115) | 3.86626647 |
| 24 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.80713533 |
| 25 | fatty acid transmembrane transport (GO:1902001) | 3.69834819 |
| 26 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.67794834 |
| 27 | positive regulation of histone deacetylation (GO:0031065) | 3.66237450 |
| 28 | membrane assembly (GO:0071709) | 3.63832824 |
| 29 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.61290906 |
| 30 | regulation of cholesterol storage (GO:0010885) | 3.58292523 |
| 31 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.57838579 |
| 32 | cardiac muscle contraction (GO:0060048) | 3.57047026 |
| 33 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.56750827 |
| 34 | 2-oxoglutarate metabolic process (GO:0006103) | 3.53000379 |
| 35 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.52704176 |
| 36 | plasma membrane repair (GO:0001778) | 3.50322161 |
| 37 | trabecula formation (GO:0060343) | 3.46654329 |
| 38 | platelet aggregation (GO:0070527) | 3.46045727 |
| 39 | negative regulation of JAK-STAT cascade (GO:0046426) | 3.43794877 |
| 40 | pinocytosis (GO:0006907) | 3.41472757 |
| 41 | regulation of platelet aggregation (GO:0090330) | 3.41221077 |
| 42 | regulation of integrin activation (GO:0033623) | 3.40028739 |
| 43 | carnitine shuttle (GO:0006853) | 3.33909983 |
| 44 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.31016973 |
| 45 | positive regulation of B cell differentiation (GO:0045579) | 3.30333514 |
| 46 | cardiac muscle cell proliferation (GO:0060038) | 3.30028695 |
| 47 | UV protection (GO:0009650) | 3.28970291 |
| 48 | regulation of relaxation of muscle (GO:1901077) | 3.27895063 |
| 49 | hypotonic response (GO:0006971) | 3.27034739 |
| 50 | hyaluronan catabolic process (GO:0030214) | 3.26993914 |
| 51 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.26342432 |
| 52 | purinergic receptor signaling pathway (GO:0035587) | 3.25485470 |
| 53 | positive regulation of vasculogenesis (GO:2001214) | 3.24013677 |
| 54 | regulation of platelet activation (GO:0010543) | 3.23224021 |
| 55 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.23197657 |
| 56 | valine metabolic process (GO:0006573) | 3.22800072 |
| 57 | regulation of gamma-delta T cell activation (GO:0046643) | 3.21117486 |
| 58 | platelet formation (GO:0030220) | 3.18608396 |
| 59 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.15102754 |
| 60 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.15102754 |
| 61 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.14188614 |
| 62 | lymph vessel development (GO:0001945) | 3.13972662 |
| 63 | response to ischemia (GO:0002931) | 3.12744777 |
| 64 | cellular extravasation (GO:0045123) | 3.10484300 |
| 65 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.08929084 |
| 66 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.07144445 |
| 67 | negative regulation of endothelial cell proliferation (GO:0001937) | 3.06890944 |
| 68 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.05333369 |
| 69 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.05173317 |
| 70 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.03978141 |
| 71 | creatine metabolic process (GO:0006600) | 3.03667865 |
| 72 | cardiac muscle cell development (GO:0055013) | 3.03630354 |
| 73 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.03005755 |
| 74 | positive regulation of mast cell activation (GO:0033005) | 3.01563860 |
| 75 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.00940444 |
| 76 | natural killer cell differentiation (GO:0001779) | 3.00541626 |
| 77 | actomyosin structure organization (GO:0031032) | 3.00526070 |
| 78 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 3.00454517 |
| 79 | regulation of fatty acid oxidation (GO:0046320) | 3.00395040 |
| 80 | definitive hemopoiesis (GO:0060216) | 2.98856035 |
| 81 | growth hormone receptor signaling pathway (GO:0060396) | 2.98763927 |
| 82 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.96773566 |
| 83 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.95198515 |
| 84 | lysine metabolic process (GO:0006553) | 2.93169446 |
| 85 | lysine catabolic process (GO:0006554) | 2.93169446 |
| 86 | regulation of mast cell degranulation (GO:0043304) | 2.91547289 |
| 87 | regulation of early endosome to late endosome transport (GO:2000641) | 2.90795028 |
| 88 | cardiac cell development (GO:0055006) | 2.89926454 |
| 89 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.88393922 |
| 90 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.87969699 |
| 91 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.87908188 |
| 92 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.87904718 |
| 93 | regulation of skeletal muscle contraction (GO:0014819) | 2.87832578 |
| 94 | regulation of cholesterol homeostasis (GO:2000188) | 2.87486812 |
| 95 | regulation of transcription initiation from RNA polymerase II promoter (GO:0060260) | 2.87169291 |
| 96 | granulocyte differentiation (GO:0030851) | 2.87154060 |
| 97 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.85280083 |
| 98 | basement membrane organization (GO:0071711) | 2.84676060 |
| 99 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.81968133 |
| 100 | negative regulation of vascular permeability (GO:0043116) | 2.81492088 |
| 101 | stress fiber assembly (GO:0043149) | 2.81366043 |
| 102 | positive regulation of receptor recycling (GO:0001921) | 2.80588641 |
| 103 | lipoxygenase pathway (GO:0019372) | 2.80131890 |
| 104 | response to muramyl dipeptide (GO:0032495) | 2.79240236 |
| 105 | tricarboxylic acid cycle (GO:0006099) | 2.79074449 |
| 106 | regulation of erythrocyte differentiation (GO:0045646) | 2.77510218 |
| 107 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.76846340 |
| 108 | germinal center formation (GO:0002467) | 2.76320007 |
| 109 | glomerular basement membrane development (GO:0032836) | 2.75109990 |
| 110 | actin-myosin filament sliding (GO:0033275) | 2.74998168 |
| 111 | muscle filament sliding (GO:0030049) | 2.74998168 |
| 112 | regulation of endothelial cell differentiation (GO:0045601) | 2.74460534 |
| 113 | endothelial cell chemotaxis (GO:0035767) | 2.74213493 |
| 114 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.74093328 |
| 115 | mammary gland development (GO:0030879) | 2.73607893 |
| 116 | negative regulation of anoikis (GO:2000811) | 2.71456598 |
| 117 | striated muscle contraction (GO:0006941) | 2.71169025 |
| 118 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.70077325 |
| 119 | response to thyroid hormone (GO:0097066) | 2.69704183 |
| 120 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.68901885 |
| 121 | regulation of leukocyte degranulation (GO:0043300) | 2.68306085 |
| 122 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.68036328 |
| 123 | protein carboxylation (GO:0018214) | 2.68036328 |
| 124 | negative regulation of platelet activation (GO:0010544) | 2.67909713 |
| 125 | positive thymic T cell selection (GO:0045059) | 2.67027436 |
| 126 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.66886172 |
| 127 | alpha-linolenic acid metabolic process (GO:0036109) | 2.65732632 |
| 128 | blood coagulation, intrinsic pathway (GO:0007597) | 2.65245437 |
| 129 | melanin biosynthetic process (GO:0042438) | 2.65125146 |
| 130 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.63918901 |
| 131 | negative regulation of oxidoreductase activity (GO:0051354) | 2.63853361 |
| 132 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.62931756 |
| 133 | response to peptidoglycan (GO:0032494) | 2.62390078 |
| 134 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.61952607 |
| 135 | cardiolipin metabolic process (GO:0032048) | 2.61782705 |
| 136 | protein localization to endosome (GO:0036010) | 2.61631442 |
| 137 | leukocyte degranulation (GO:0043299) | 2.60857093 |
| 138 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.59214634 |
| 139 | platelet activation (GO:0030168) | 2.58447012 |
| 140 | granulocyte activation (GO:0036230) | 2.56718965 |
| 141 | negative regulation of stress fiber assembly (GO:0051497) | 2.56713008 |
| 142 | establishment of endothelial barrier (GO:0061028) | 2.56014992 |
| 143 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.55962501 |
| 144 | endothelium development (GO:0003158) | 2.53679947 |
| 145 | skin morphogenesis (GO:0043589) | 2.52591255 |
| 146 | morphogenesis of an endothelium (GO:0003159) | 2.52458004 |
| 147 | endothelial tube morphogenesis (GO:0061154) | 2.52458004 |
| 148 | positive regulation of myotube differentiation (GO:0010831) | 2.52289969 |
| 149 | negative regulation of granulocyte differentiation (GO:0030853) | 2.51696982 |
| 150 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.51682623 |
| 151 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.51682623 |
| 152 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.51568668 |
| 153 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.51014909 |
| 154 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.50967143 |
| 155 | cardiac muscle hypertrophy (GO:0003300) | 2.50793643 |
| 156 | blood vessel maturation (GO:0001955) | 2.50206528 |
| 157 | cellular response to growth hormone stimulus (GO:0071378) | 2.49817170 |
| 158 | vasculogenesis (GO:0001570) | 2.49568143 |
| 159 | muscle atrophy (GO:0014889) | 2.49397231 |
| 160 | positive regulation of fatty acid oxidation (GO:0046321) | 2.49347090 |
| 161 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.49289486 |
| 162 | tricarboxylic acid metabolic process (GO:0072350) | 2.49266374 |
| 163 | neutrophil activation (GO:0042119) | 2.47980097 |
| 164 | adherens junction assembly (GO:0034333) | 2.47918480 |
| 165 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.47487564 |
| 166 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.47281377 |
| 167 | melanin metabolic process (GO:0006582) | 2.46804296 |
| 168 | oxaloacetate metabolic process (GO:0006107) | 2.46536832 |
| 169 | cell-substrate adherens junction assembly (GO:0007045) | 2.45970118 |
| 170 | focal adhesion assembly (GO:0048041) | 2.45970118 |
| 171 | venous blood vessel morphogenesis (GO:0048845) | 2.45732574 |
| 172 | regulation of anoikis (GO:2000209) | 2.45389075 |
| 173 | striated muscle cell proliferation (GO:0014855) | 2.45334596 |
| 174 | GDP-mannose metabolic process (GO:0019673) | 2.43280872 |
| 175 | heart valve formation (GO:0003188) | 2.43178992 |
| 176 | regulation of vasculogenesis (GO:2001212) | 2.43010200 |
| 177 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.41798548 |
| 178 | NIK/NF-kappaB signaling (GO:0038061) | 2.41615702 |
| 179 | myeloid cell development (GO:0061515) | 2.41356474 |
| 180 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.41208557 |
| 181 | homotypic cell-cell adhesion (GO:0034109) | 2.40161827 |
| 182 | platelet degranulation (GO:0002576) | 2.39858247 |
| 183 | myeloid cell activation involved in immune response (GO:0002275) | 2.37682109 |
| 184 | modulation by virus of host process (GO:0019054) | 2.35039448 |
| 185 | response to laminar fluid shear stress (GO:0034616) | 2.33696974 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.78465942 |
| 2 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.42665890 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.18450895 |
| 4 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.79498945 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.62464781 |
| 6 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.53594947 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.41929247 |
| 8 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.38528897 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.37189997 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.35143926 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.31550987 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 2.30412781 |
| 13 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.26274467 |
| 14 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.26274467 |
| 15 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.21763969 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.20323680 |
| 17 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.14849757 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.14782610 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.11372149 |
| 20 | MAF_26560356_Chip-Seq_TH2_Human | 2.02763997 |
| 21 | P68_20966046_ChIP-Seq_HELA_Human | 2.00445965 |
| 22 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.99465924 |
| 23 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.94589456 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.94461655 |
| 25 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.94335725 |
| 26 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.93179621 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.91987679 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.90730527 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.89966065 |
| 30 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.89511158 |
| 31 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.88346428 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.87309429 |
| 33 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.87066166 |
| 34 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.86729835 |
| 35 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.79174856 |
| 36 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.77906191 |
| 37 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.77127622 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.72210420 |
| 39 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.67964497 |
| 40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.67043994 |
| 41 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.66963520 |
| 42 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.64747009 |
| 43 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.63975502 |
| 44 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.63396308 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61146148 |
| 46 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.59013149 |
| 47 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57314023 |
| 48 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.55798195 |
| 49 | MAF_26560356_Chip-Seq_TH1_Human | 1.55633368 |
| 50 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52066818 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.50261105 |
| 52 | GATA1_19941826_ChIP-Seq_K562_Human | 1.49818368 |
| 53 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.49362179 |
| 54 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.49174867 |
| 55 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.49076474 |
| 56 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.48914645 |
| 57 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.48724135 |
| 58 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.47119350 |
| 59 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.43833771 |
| 60 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.42542035 |
| 61 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.40884836 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.39768783 |
| 63 | UTX_26944678_Chip-Seq_JUKART_Human | 1.39331194 |
| 64 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.38311005 |
| 65 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.35626600 |
| 66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.35274727 |
| 67 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.34951626 |
| 68 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.34153958 |
| 69 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33325680 |
| 70 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.31596223 |
| 71 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.31511140 |
| 72 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.31457018 |
| 73 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30182577 |
| 74 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29926835 |
| 75 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.28295990 |
| 76 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.26786802 |
| 77 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.26076055 |
| 78 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.24874406 |
| 79 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.24570234 |
| 80 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.24146289 |
| 81 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.23860388 |
| 82 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.22940550 |
| 83 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22878247 |
| 84 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.22835175 |
| 85 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.22630700 |
| 86 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.22248313 |
| 87 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.21985637 |
| 88 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.21846831 |
| 89 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.21331798 |
| 90 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.20030626 |
| 91 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18962237 |
| 92 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.18841775 |
| 93 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18371461 |
| 94 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.18361630 |
| 95 | KDM2B_26808549_Chip-Seq_K562_Human | 1.17989045 |
| 96 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.17897618 |
| 97 | SPI1_23127762_ChIP-Seq_K562_Human | 1.17155028 |
| 98 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16616169 |
| 99 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.16276233 |
| 100 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.15951876 |
| 101 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.15174575 |
| 102 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.14830767 |
| 103 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13446319 |
| 104 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.12742021 |
| 105 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.12658060 |
| 106 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.12066554 |
| 107 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11754822 |
| 108 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11545839 |
| 109 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.10990671 |
| 110 | GATA2_19941826_ChIP-Seq_K562_Human | 1.10648568 |
| 111 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09334258 |
| 112 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.08970077 |
| 113 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08490761 |
| 114 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.07626676 |
| 115 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06754068 |
| 116 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.06730597 |
| 117 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06529948 |
| 118 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.05516146 |
| 119 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05266363 |
| 120 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.04757442 |
| 121 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.04694816 |
| 122 | MYB_26560356_Chip-Seq_TH1_Human | 1.04463114 |
| 123 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.04208026 |
| 124 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03447640 |
| 125 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03192925 |
| 126 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02936629 |
| 127 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02510206 |
| 128 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02196750 |
| 129 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.01749137 |
| 130 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.01078139 |
| 131 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.00614617 |
| 132 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.99980684 |
| 133 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99585769 |
| 134 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98970271 |
| 135 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98421370 |
| 136 | SA1_27219007_Chip-Seq_Bcells_Human | 0.97781601 |
| 137 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.97392941 |
| 138 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.96563568 |
| 139 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95356206 |
| 140 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.94331518 |
| 141 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93964757 |
| 142 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.93105126 |
| 143 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.89590785 |
| 144 | ATF3_27146783_Chip-Seq_COLON_Human | 0.88563170 |
| 145 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.88235330 |
| 146 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88046666 |
| 147 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.87802517 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.87918019 |
| 2 | MP0003191_abnormal_cellular_cholesterol | 5.74121248 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 4.83025193 |
| 4 | MP0009780_abnormal_chondrocyte_physiolo | 4.68603220 |
| 5 | MP0005464_abnormal_platelet_physiology | 4.29945675 |
| 6 | MP0003950_abnormal_plasma_membrane | 4.10492994 |
| 7 | MP0005409_darkened_coat_color | 3.76615443 |
| 8 | MP0003828_pulmonary_edema | 3.45903607 |
| 9 | MP0005171_absent_coat_pigmentation | 3.20921230 |
| 10 | MP0004084_abnormal_cardiac_muscle | 3.06293400 |
| 11 | MP0010368_abnormal_lymphatic_system | 3.05008714 |
| 12 | MP0002332_abnormal_exercise_endurance | 2.81871604 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 2.78369179 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.74205970 |
| 15 | MP0003045_fibrosis | 2.61230941 |
| 16 | MP0006138_congestive_heart_failure | 2.53831750 |
| 17 | MP0003646_muscle_fatigue | 2.51556820 |
| 18 | MP0001879_abnormal_lymphatic_vessel | 2.48853572 |
| 19 | MP0005330_cardiomyopathy | 2.39309326 |
| 20 | MP0003724_increased_susceptibility_to | 2.36233332 |
| 21 | MP0000751_myopathy | 2.34231116 |
| 22 | MP0000465_gastrointestinal_hemorrhage | 2.24908944 |
| 23 | MP0001853_heart_inflammation | 2.23525218 |
| 24 | MP0008004_abnormal_stomach_pH | 2.21252522 |
| 25 | MP0002877_abnormal_melanocyte_morpholog | 2.11909303 |
| 26 | MP0005174_abnormal_tail_pigmentation | 2.09322979 |
| 27 | MP0004036_abnormal_muscle_relaxation | 2.01470921 |
| 28 | MP0003136_yellow_coat_color | 2.00303238 |
| 29 | MP0004215_abnormal_myocardial_fiber | 1.95691023 |
| 30 | MP0003436_decreased_susceptibility_to | 1.94573303 |
| 31 | MP0004130_abnormal_muscle_cell | 1.90838641 |
| 32 | MP0001544_abnormal_cardiovascular_syste | 1.84958753 |
| 33 | MP0005385_cardiovascular_system_phenoty | 1.84958753 |
| 34 | MP0000013_abnormal_adipose_tissue | 1.84845331 |
| 35 | MP0009840_abnormal_foam_cell | 1.76864436 |
| 36 | MP0000015_abnormal_ear_pigmentation | 1.73271848 |
| 37 | MP0004087_abnormal_muscle_fiber | 1.71295812 |
| 38 | MP0004510_myositis | 1.68119816 |
| 39 | MP0002972_abnormal_cardiac_muscle | 1.64681780 |
| 40 | MP0010630_abnormal_cardiac_muscle | 1.64304842 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.62191305 |
| 42 | MP0009278_abnormal_bone_marrow | 1.60853626 |
| 43 | MP0000750_abnormal_muscle_regeneration | 1.55283741 |
| 44 | MP0005451_abnormal_body_composition | 1.54450930 |
| 45 | MP0004381_abnormal_hair_follicle | 1.52387072 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.49719479 |
| 47 | MP0004147_increased_porphyrin_level | 1.46989649 |
| 48 | MP0003453_abnormal_keratinocyte_physiol | 1.45559848 |
| 49 | MP0001986_abnormal_taste_sensitivity | 1.44938300 |
| 50 | MP0000003_abnormal_adipose_tissue | 1.41833599 |
| 51 | MP0001835_abnormal_antigen_presentation | 1.40031131 |
| 52 | MP0002398_abnormal_bone_marrow | 1.36965091 |
| 53 | MP0000685_abnormal_immune_system | 1.36016761 |
| 54 | MP0002148_abnormal_hypersensitivity_rea | 1.35641289 |
| 55 | MP0004272_abnormal_basement_membrane | 1.34281232 |
| 56 | MP0002419_abnormal_innate_immunity | 1.32117812 |
| 57 | MP0004484_altered_response_of | 1.28935977 |
| 58 | MP0005620_abnormal_muscle_contractility | 1.28146954 |
| 59 | MP0005165_increased_susceptibility_to | 1.27391057 |
| 60 | MP0010352_gastrointestinal_tract_polyps | 1.27321332 |
| 61 | MP0003091_abnormal_cell_migration | 1.27301197 |
| 62 | MP0005167_abnormal_blood-brain_barrier | 1.26339145 |
| 63 | MP0001661_extended_life_span | 1.26050393 |
| 64 | MP0003300_gastrointestinal_ulcer | 1.25655383 |
| 65 | MP0003195_calcinosis | 1.25635387 |
| 66 | MP0000767_abnormal_smooth_muscle | 1.24948119 |
| 67 | MP0008775_abnormal_heart_ventricle | 1.23476261 |
| 68 | MP0003879_abnormal_hair_cell | 1.20716125 |
| 69 | MP0005000_abnormal_immune_tolerance | 1.20248390 |
| 70 | MP0002106_abnormal_muscle_physiology | 1.20124150 |
| 71 | MP0005025_abnormal_response_to | 1.17158626 |
| 72 | MP0005670_abnormal_white_adipose | 1.16782062 |
| 73 | MP0003279_aneurysm | 1.16551553 |
| 74 | MP0005083_abnormal_biliary_tract | 1.15080178 |
| 75 | MP0002723_abnormal_immune_serum | 1.14320689 |
| 76 | MP0003448_altered_tumor_morphology | 1.13885730 |
| 77 | MP0003221_abnormal_cardiomyocyte_apopto | 1.12528870 |
| 78 | MP0005623_abnormal_meninges_morphology | 1.11643692 |
| 79 | MP0002168_other_aberrant_phenotype | 1.10041408 |
| 80 | MP0002429_abnormal_blood_cell | 1.09716232 |
| 81 | MP0003763_abnormal_thymus_physiology | 1.09471597 |
| 82 | MP0002420_abnormal_adaptive_immunity | 1.07497423 |
| 83 | MP0001819_abnormal_immune_cell | 1.07411031 |
| 84 | MP0004185_abnormal_adipocyte_glucose | 1.06865581 |
| 85 | MP0001851_eye_inflammation | 1.06510488 |
| 86 | MP0002722_abnormal_immune_system | 1.04502936 |
| 87 | MP0005671_abnormal_response_to | 1.03773641 |
| 88 | MP0003567_abnormal_fetal_cardiomyocyte | 1.03717875 |
| 89 | MP0003566_abnormal_cell_adhesion | 1.03667601 |
| 90 | MP0001188_hyperpigmentation | 1.03515649 |
| 91 | MP0002396_abnormal_hematopoietic_system | 1.03225183 |
| 92 | MP0005387_immune_system_phenotype | 1.03140856 |
| 93 | MP0001790_abnormal_immune_system | 1.03140856 |
| 94 | MP0000858_altered_metastatic_potential | 1.03133949 |
| 95 | MP0002452_abnormal_antigen_presenting | 1.02963446 |
| 96 | MP0002269_muscular_atrophy | 1.01972980 |
| 97 | MP0005377_hearing/vestibular/ear_phenot | 1.01443620 |
| 98 | MP0003878_abnormal_ear_physiology | 1.01443620 |
| 99 | MP0005266_abnormal_metabolism | 1.00655706 |
| 100 | MP0004947_skin_inflammation | 0.99029285 |
| 101 | MP0000749_muscle_degeneration | 0.97773590 |
| 102 | MP0000716_abnormal_immune_system | 0.97116390 |
| 103 | MP0000703_abnormal_thymus_morphology | 0.96491630 |
| 104 | MP0000689_abnormal_spleen_morphology | 0.96479827 |
| 105 | MP0000759_abnormal_skeletal_muscle | 0.96021850 |
| 106 | MP0002998_abnormal_bone_remodeling | 0.95333414 |
| 107 | MP0005666_abnormal_adipose_tissue | 0.91882308 |
| 108 | MP0002405_respiratory_system_inflammati | 0.91851878 |
| 109 | MP0009785_altered_susceptibility_to | 0.91099844 |
| 110 | MP0000678_abnormal_parathyroid_gland | 0.91051724 |
| 111 | MP0003075_altered_response_to | 0.90683685 |
| 112 | MP0005369_muscle_phenotype | 0.90318014 |
| 113 | MP0005397_hematopoietic_system_phenotyp | 0.89804598 |
| 114 | MP0001545_abnormal_hematopoietic_system | 0.89804598 |
| 115 | MP0005085_abnormal_gallbladder_physiolo | 0.86533949 |
| 116 | MP0003252_abnormal_bile_duct | 0.83612825 |
| 117 | MP0003303_peritoneal_inflammation | 0.83534598 |
| 118 | MP0002132_abnormal_respiratory_system | 0.83081693 |
| 119 | MP0000343_altered_response_to | 0.81345703 |
| 120 | MP0004808_abnormal_hematopoietic_stem | 0.80871274 |
| 121 | MP0000266_abnormal_heart_morphology | 0.80478487 |
| 122 | MP0002933_joint_inflammation | 0.79098736 |
| 123 | MP0001915_intracranial_hemorrhage | 0.78571475 |
| 124 | MP0005076_abnormal_cell_differentiation | 0.78448531 |
| 125 | MP0008260_abnormal_autophagy | 0.78059741 |
| 126 | MP0000733_abnormal_muscle_development | 0.77835610 |
| 127 | MP0001849_ear_inflammation | 0.77793759 |
| 128 | MP0000249_abnormal_blood_vessel | 0.77311507 |
| 129 | MP0000230_abnormal_systemic_arterial | 0.76929133 |
| 130 | MP0005595_abnormal_vascular_smooth | 0.76601576 |
| 131 | MP0003656_abnormal_erythrocyte_physiolo | 0.75889506 |
| 132 | MP0004883_abnormal_blood_vessel | 0.75695351 |
| 133 | MP0010155_abnormal_intestine_physiology | 0.75589787 |
| 134 | MP0004085_abnormal_heartbeat | 0.75031818 |
| 135 | MP0005501_abnormal_skin_physiology | 0.72390162 |
| 136 | MP0000747_muscle_weakness | 0.71656955 |
| 137 | MP0005023_abnormal_wound_healing | 0.71151342 |
| 138 | MP0002128_abnormal_blood_circulation | 0.70495113 |
| 139 | MP0009115_abnormal_fat_cell | 0.69749980 |
| 140 | MP0002971_abnormal_brown_adipose | 0.67928205 |
| 141 | MP0008875_abnormal_xenobiotic_pharmacok | 0.67627599 |
| 142 | MP0002166_altered_tumor_susceptibility | 0.67507113 |
| 143 | MP0001533_abnormal_skeleton_physiology | 0.67247468 |
| 144 | MP0008961_abnormal_basal_metabolism | 0.67015815 |
| 145 | MP0000609_abnormal_liver_physiology | 0.66619629 |
| 146 | MP0010329_abnormal_lipoprotein_level | 0.64519082 |
| 147 | MP0002127_abnormal_cardiovascular_syste | 0.64364897 |
| 148 | MP0005375_adipose_tissue_phenotype | 0.63502751 |
| 149 | MP0003137_abnormal_impulse_conducting | 0.63058303 |
| 150 | MP0002139_abnormal_hepatobiliary_system | 0.61746432 |
| 151 | MP0001800_abnormal_humoral_immune | 0.60741311 |
| 152 | MP0008438_abnormal_cutaneous_collagen | 0.57707168 |
| 153 | MP0008874_decreased_physiological_sensi | 0.54741098 |
| 154 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.53991944 |
| 155 | MP0002925_abnormal_cardiovascular_devel | 0.52300737 |
| 156 | MP0001614_abnormal_blood_vessel | 0.51788418 |
| 157 | MP0009643_abnormal_urine_homeostasis | 0.51444743 |
| 158 | MP0001542_abnormal_bone_strength | 0.51012713 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 6.30479395 |
| 2 | Petechiae (HP:0000967) | 6.14672495 |
| 3 | Purpura (HP:0000979) | 5.49004662 |
| 4 | Increased mean platelet volume (HP:0011877) | 5.29189827 |
| 5 | Abnormal platelet volume (HP:0011876) | 5.22341215 |
| 6 | Sudden death (HP:0001699) | 4.94711346 |
| 7 | Menorrhagia (HP:0000132) | 4.91101424 |
| 8 | Epistaxis (HP:0000421) | 4.83343536 |
| 9 | Growth hormone excess (HP:0000845) | 4.53583717 |
| 10 | Reduced subcutaneous adipose tissue (HP:0003758) | 4.45486415 |
| 11 | Glucose intolerance (HP:0000833) | 4.40098094 |
| 12 | Ventricular tachycardia (HP:0004756) | 4.32957366 |
| 13 | Hypercholesterolemia (HP:0003124) | 3.99394986 |
| 14 | Lipoatrophy (HP:0100578) | 3.92245258 |
| 15 | Muscle fiber splitting (HP:0003555) | 3.82875220 |
| 16 | Impaired platelet aggregation (HP:0003540) | 3.81724662 |
| 17 | Abnormal platelet function (HP:0011869) | 3.81724662 |
| 18 | Xerostomia (HP:0000217) | 3.73086901 |
| 19 | Atrial fibrillation (HP:0005110) | 3.63819337 |
| 20 | Hyporeflexia of lower limbs (HP:0002600) | 3.55722886 |
| 21 | Primary atrial arrhythmia (HP:0001692) | 3.53735113 |
| 22 | Gingival bleeding (HP:0000225) | 3.52667305 |
| 23 | Spontaneous hematomas (HP:0007420) | 3.51785874 |
| 24 | Exercise-induced muscle cramps (HP:0003710) | 3.47240767 |
| 25 | Increased connective tissue (HP:0009025) | 3.46183972 |
| 26 | Polycythemia (HP:0001901) | 3.46022727 |
| 27 | Hemorrhage of the eye (HP:0011885) | 3.38288538 |
| 28 | Orthostatic hypotension (HP:0001278) | 3.37822259 |
| 29 | Dyschromatopsia (HP:0007641) | 3.37440174 |
| 30 | Supraventricular arrhythmia (HP:0005115) | 3.35353596 |
| 31 | Supraventricular tachycardia (HP:0004755) | 3.34640999 |
| 32 | Exercise-induced myalgia (HP:0003738) | 3.32855429 |
| 33 | Thin bony cortex (HP:0002753) | 3.32501009 |
| 34 | Bone cyst (HP:0012062) | 3.26378303 |
| 35 | Deep venous thrombosis (HP:0002625) | 3.26275335 |
| 36 | Hypertensive crisis (HP:0100735) | 3.19369042 |
| 37 | Subaortic stenosis (HP:0001682) | 3.15545059 |
| 38 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.15545059 |
| 39 | Abnormal glucose tolerance (HP:0001952) | 3.14080164 |
| 40 | Calf muscle hypertrophy (HP:0008981) | 3.10694376 |
| 41 | Camptodactyly of toe (HP:0001836) | 3.08474182 |
| 42 | Nonimmune hydrops fetalis (HP:0001790) | 3.06398536 |
| 43 | Right ventricular cardiomyopathy (HP:0011663) | 3.05982861 |
| 44 | Mucosal telangiectasiae (HP:0100579) | 3.01283999 |
| 45 | Atrioventricular block (HP:0001678) | 2.98278592 |
| 46 | Chondrocalcinosis (HP:0000934) | 2.93969987 |
| 47 | Bundle branch block (HP:0011710) | 2.86398279 |
| 48 | Abnormality of the nasal mucosa (HP:0000433) | 2.81820635 |
| 49 | Cerebral hemorrhage (HP:0001342) | 2.80614527 |
| 50 | EMG: myopathic abnormalities (HP:0003458) | 2.79579197 |
| 51 | Difficulty running (HP:0009046) | 2.79361744 |
| 52 | Mesangial abnormality (HP:0001966) | 2.78057986 |
| 53 | Large hands (HP:0001176) | 2.75023573 |
| 54 | Facial diplegia (HP:0001349) | 2.74855998 |
| 55 | Myoglobinuria (HP:0002913) | 2.74509885 |
| 56 | Testicular atrophy (HP:0000029) | 2.74004912 |
| 57 | Abnormality of the calf musculature (HP:0001430) | 2.69567915 |
| 58 | Ulnar bowing (HP:0003031) | 2.69523035 |
| 59 | Abnormality of Sharpey fibers (HP:0100685) | 2.68556779 |
| 60 | Insulin resistance (HP:0000855) | 2.68278318 |
| 61 | Acanthosis nigricans (HP:0000956) | 2.67204926 |
| 62 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.65575435 |
| 63 | Joint contractures involving the joints of the feet (HP:0100492) | 2.62893733 |
| 64 | Flexion contracture of toe (HP:0005830) | 2.62893733 |
| 65 | Difficulty climbing stairs (HP:0003551) | 2.62079297 |
| 66 | Lymphangioma (HP:0100764) | 2.61344201 |
| 67 | Dysostosis multiplex (HP:0000943) | 2.60599738 |
| 68 | Heart block (HP:0012722) | 2.57827092 |
| 69 | Asymmetric septal hypertrophy (HP:0001670) | 2.56526309 |
| 70 | Joint hemorrhage (HP:0005261) | 2.54357933 |
| 71 | Cerebral aneurysm (HP:0004944) | 2.54112069 |
| 72 | Annular pancreas (HP:0001734) | 2.53875300 |
| 73 | Dilated cardiomyopathy (HP:0001644) | 2.50297712 |
| 74 | Abnormality of macrophages (HP:0004311) | 2.48617168 |
| 75 | Syncope (HP:0001279) | 2.46545849 |
| 76 | Abnormality of the common coagulation pathway (HP:0010990) | 2.44904749 |
| 77 | Abnormal atrioventricular conduction (HP:0005150) | 2.43536167 |
| 78 | Cellulitis (HP:0100658) | 2.39538765 |
| 79 | Obstructive lung disease (HP:0006536) | 2.39412529 |
| 80 | Chronic obstructive pulmonary disease (HP:0006510) | 2.39412529 |
| 81 | Bruising susceptibility (HP:0000978) | 2.38730242 |
| 82 | Prolonged QT interval (HP:0001657) | 2.36175107 |
| 83 | Increased variability in muscle fiber diameter (HP:0003557) | 2.35435043 |
| 84 | Hematochezia (HP:0002573) | 2.32917386 |
| 85 | Ventricular fibrillation (HP:0001663) | 2.32772671 |
| 86 | Colitis (HP:0002583) | 2.28700430 |
| 87 | Acrocyanosis (HP:0001063) | 2.27585537 |
| 88 | Abnormality of glycolipid metabolism (HP:0010969) | 2.26406129 |
| 89 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.26406129 |
| 90 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.26406129 |
| 91 | Hypertriglyceridemia (HP:0002155) | 2.26131901 |
| 92 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.24965180 |
| 93 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.24965180 |
| 94 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.24965180 |
| 95 | Thrombocytosis (HP:0001894) | 2.23192771 |
| 96 | Myocardial infarction (HP:0001658) | 2.20958835 |
| 97 | Conjunctival telangiectasia (HP:0000524) | 2.20875834 |
| 98 | Broad metatarsal (HP:0001783) | 2.20595501 |
| 99 | Dysmetric saccades (HP:0000641) | 2.17810031 |
| 100 | Eczematoid dermatitis (HP:0000976) | 2.16486615 |
| 101 | Gastrointestinal stroma tumor (HP:0100723) | 2.15982354 |
| 102 | Increased cerebral lipofuscin (HP:0011813) | 2.15434720 |
| 103 | Ketoacidosis (HP:0001993) | 2.15249737 |
| 104 | Joint stiffness (HP:0001387) | 2.14273744 |
| 105 | Distal lower limb amyotrophy (HP:0008944) | 2.13845961 |
| 106 | Intestinal fistula (HP:0100819) | 2.12992105 |
| 107 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.11067251 |
| 108 | Ventricular arrhythmia (HP:0004308) | 2.10890522 |
| 109 | Pulmonary infiltrates (HP:0002113) | 2.10543942 |
| 110 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.09921909 |
| 111 | Recurrent abscess formation (HP:0002722) | 2.09151260 |
| 112 | Hepatosplenomegaly (HP:0001433) | 2.08996063 |
| 113 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.08733942 |
| 114 | Myotonia (HP:0002486) | 2.08551667 |
| 115 | Visceral angiomatosis (HP:0100761) | 2.07325905 |
| 116 | Hyperthyroidism (HP:0000836) | 2.06666213 |
| 117 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.04956713 |
| 118 | Mucopolysacchariduria (HP:0008155) | 2.04956713 |
| 119 | Palpitations (HP:0001962) | 2.00177996 |
| 120 | Aneurysm (HP:0002617) | 2.00125473 |
| 121 | Congestive heart failure (HP:0001635) | 1.99232490 |
| 122 | Chest pain (HP:0100749) | 1.97189874 |
| 123 | Abnormality of the intrinsic pathway (HP:0010989) | 1.95540201 |
| 124 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.93828926 |
| 125 | Striae distensae (HP:0001065) | 1.92949296 |
| 126 | Abnormality of the fingertips (HP:0001211) | 1.92474987 |
| 127 | Hyperlipoproteinemia (HP:0010980) | 1.92303825 |
| 128 | Poikilocytosis (HP:0004447) | 1.92128365 |
| 129 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.91932657 |
| 130 | Anteriorly placed anus (HP:0001545) | 1.90434801 |
| 131 | Agammaglobulinemia (HP:0004432) | 1.89441873 |
| 132 | Ankle contracture (HP:0006466) | 1.89039310 |
| 133 | Muscle stiffness (HP:0003552) | 1.88463529 |
| 134 | Gastrointestinal inflammation (HP:0004386) | 1.88179245 |
| 135 | Verrucae (HP:0200043) | 1.88142785 |
| 136 | Papilloma (HP:0012740) | 1.88142785 |
| 137 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.87875063 |
| 138 | Capillary hemangiomas (HP:0005306) | 1.87768676 |
| 139 | Hemangiomatosis (HP:0007461) | 1.87594658 |
| 140 | Male infertility (HP:0003251) | 1.86859925 |
| 141 | Hyperpituitarism (HP:0010514) | 1.86688512 |
| 142 | Abnormality of the hepatic vasculature (HP:0006707) | 1.86329504 |
| 143 | Clonus (HP:0002169) | 1.86298958 |
| 144 | Bulbar palsy (HP:0001283) | 1.85911667 |
| 145 | Myopathic facies (HP:0002058) | 1.85854712 |
| 146 | Ketosis (HP:0001946) | 1.85354422 |
| 147 | Fatigue (HP:0012378) | 1.85345733 |
| 148 | Recurrent bronchitis (HP:0002837) | 1.83995037 |
| 149 | Squamous cell carcinoma (HP:0002860) | 1.83558764 |
| 150 | Lymphedema (HP:0001004) | 1.82870819 |
| 151 | Sudden cardiac death (HP:0001645) | 1.82729813 |
| 152 | Recurrent bacterial skin infections (HP:0005406) | 1.82395851 |
| 153 | Prominent supraorbital ridges (HP:0000336) | 1.81740790 |
| 154 | Rib fusion (HP:0000902) | 1.81058780 |
| 155 | Limb-girdle muscle atrophy (HP:0003797) | 1.80776584 |
| 156 | Hypotension (HP:0002615) | 1.80428166 |
| 157 | Protrusio acetabuli (HP:0003179) | 1.80376310 |
| 158 | Inflammation of the large intestine (HP:0002037) | 1.79843781 |
| 159 | Rhabdomyolysis (HP:0003201) | 1.79223917 |
| 160 | Vaginal fistula (HP:0004320) | 1.79154556 |
| 161 | Hypoplastic ischia (HP:0003175) | 1.78871537 |
| 162 | Arterial thrombosis (HP:0004420) | 1.78390301 |
| 163 | Mitral stenosis (HP:0001718) | 1.77689730 |
| 164 | Esophageal varix (HP:0002040) | 1.77432932 |
| 165 | Emphysema (HP:0002097) | 1.76799360 |
| 166 | Increased serum ferritin (HP:0003281) | 1.76766181 |
| 167 | Rectal fistula (HP:0100590) | 1.76555066 |
| 168 | Rectovaginal fistula (HP:0000143) | 1.76555066 |
| 169 | Abnormality of the costochondral junction (HP:0000919) | 1.76511488 |
| 170 | Venous insufficiency (HP:0005293) | 1.76455524 |
| 171 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.71575390 |
| 172 | Premature graying of hair (HP:0002216) | 1.71175186 |
| 173 | Ocular albinism (HP:0001107) | 1.70701526 |
| 174 | Stroke (HP:0001297) | 1.69755031 |
| 175 | Truncus arteriosus (HP:0001660) | 1.68922734 |
| 176 | Venous abnormality (HP:0002624) | 1.68509946 |
| 177 | Easy fatigability (HP:0003388) | 1.68495795 |
| 178 | Hypoplasia of the iris (HP:0007676) | 1.66292466 |
| 179 | Thin ribs (HP:0000883) | 1.65811918 |
| 180 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.65257488 |
| 181 | Paralysis (HP:0003470) | 1.65066726 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 4.72762505 |
| 2 | TRIB3 | 4.13062317 |
| 3 | EPHB1 | 3.84450312 |
| 4 | TTN | 3.50020584 |
| 5 | RIPK4 | 3.42073031 |
| 6 | PKN2 | 2.91951959 |
| 7 | MAPK15 | 2.73434979 |
| 8 | ERN1 | 2.64855911 |
| 9 | MAP4K1 | 2.63435343 |
| 10 | PRPF4B | 2.54424747 |
| 11 | BLK | 2.38748119 |
| 12 | EEF2K | 2.36476290 |
| 13 | FES | 2.36271353 |
| 14 | TYK2 | 2.32058362 |
| 15 | PTK6 | 2.24715375 |
| 16 | MAP3K10 | 2.16360261 |
| 17 | FGFR4 | 2.14188291 |
| 18 | DMPK | 2.12981246 |
| 19 | MYLK | 1.96529040 |
| 20 | KDR | 1.84509623 |
| 21 | MST4 | 1.79068185 |
| 22 | TGFBR2 | 1.78951894 |
| 23 | LMTK2 | 1.70791601 |
| 24 | TESK2 | 1.67578554 |
| 25 | BCKDK | 1.67508034 |
| 26 | JAK1 | 1.62254842 |
| 27 | MAPKAPK3 | 1.55435537 |
| 28 | CSF1R | 1.45597844 |
| 29 | GRK6 | 1.39346543 |
| 30 | TGFBR1 | 1.36583929 |
| 31 | CDK12 | 1.35858302 |
| 32 | NME2 | 1.34799463 |
| 33 | IRAK3 | 1.34543240 |
| 34 | PTK2B | 1.32838372 |
| 35 | RIPK1 | 1.32221770 |
| 36 | TEC | 1.30645177 |
| 37 | TAOK2 | 1.30427421 |
| 38 | MAP3K11 | 1.29621351 |
| 39 | NEK9 | 1.28101514 |
| 40 | PIK3CG | 1.26251277 |
| 41 | SMG1 | 1.21694886 |
| 42 | MAP3K6 | 1.17558094 |
| 43 | TBK1 | 1.17348278 |
| 44 | PRKG2 | 1.16202876 |
| 45 | PHKG2 | 1.12893185 |
| 46 | PHKG1 | 1.12893185 |
| 47 | LRRK2 | 1.10551358 |
| 48 | DYRK1B | 1.07689726 |
| 49 | CSK | 1.06777372 |
| 50 | FLT3 | 1.06572024 |
| 51 | PDK3 | 1.02833086 |
| 52 | PDK4 | 1.02833086 |
| 53 | MAP3K3 | 1.00731634 |
| 54 | MAP3K1 | 0.99756550 |
| 55 | STK10 | 0.98299538 |
| 56 | PAK4 | 0.97436489 |
| 57 | PDGFRA | 0.96289698 |
| 58 | FGFR3 | 0.94756889 |
| 59 | KSR2 | 0.91556302 |
| 60 | EPHA3 | 0.90788076 |
| 61 | MAP3K7 | 0.89944134 |
| 62 | PRKD1 | 0.82904407 |
| 63 | DDR2 | 0.82231133 |
| 64 | SIK3 | 0.81326284 |
| 65 | STK24 | 0.80643701 |
| 66 | SIK1 | 0.80488531 |
| 67 | BTK | 0.80275161 |
| 68 | MAP3K13 | 0.79853433 |
| 69 | CDK19 | 0.78350250 |
| 70 | WNK1 | 0.77139243 |
| 71 | JAK2 | 0.75807245 |
| 72 | PAK3 | 0.74314513 |
| 73 | KIT | 0.73602796 |
| 74 | LYN | 0.73021709 |
| 75 | RPS6KA2 | 0.72658312 |
| 76 | PRKCH | 0.72543609 |
| 77 | IKBKB | 0.72320790 |
| 78 | MAPK7 | 0.72129083 |
| 79 | PRKD2 | 0.71898793 |
| 80 | MARK2 | 0.71286220 |
| 81 | TYRO3 | 0.71102072 |
| 82 | MAPK12 | 0.70771433 |
| 83 | LCK | 0.67028513 |
| 84 | ICK | 0.66273794 |
| 85 | EIF2AK1 | 0.65673909 |
| 86 | PAK1 | 0.65380440 |
| 87 | NLK | 0.65354709 |
| 88 | HIPK2 | 0.63658856 |
| 89 | MAP2K3 | 0.62614653 |
| 90 | MAP2K6 | 0.62267801 |
| 91 | IRAK2 | 0.61863793 |
| 92 | PIM2 | 0.59933758 |
| 93 | MAP3K14 | 0.59103910 |
| 94 | WNK4 | 0.58775304 |
| 95 | RAF1 | 0.58051932 |
| 96 | STK4 | 0.57425169 |
| 97 | TLK1 | 0.57166364 |
| 98 | ABL1 | 0.56183281 |
| 99 | PDK1 | 0.55961653 |
| 100 | RPS6KC1 | 0.55903435 |
| 101 | RPS6KL1 | 0.55903435 |
| 102 | PDGFRB | 0.55894033 |
| 103 | IKBKE | 0.55150602 |
| 104 | HCK | 0.54854136 |
| 105 | CDK6 | 0.52851544 |
| 106 | MAP3K8 | 0.52735558 |
| 107 | MTOR | 0.52174531 |
| 108 | CDK4 | 0.52069122 |
| 109 | EPHB2 | 0.51900181 |
| 110 | STK3 | 0.51198503 |
| 111 | ALK | 0.51020188 |
| 112 | DAPK3 | 0.49908208 |
| 113 | ILK | 0.49666876 |
| 114 | PDPK1 | 0.48529533 |
| 115 | RPS6KA6 | 0.47512937 |
| 116 | FYN | 0.47476110 |
| 117 | MAPK4 | 0.47277512 |
| 118 | JAK3 | 0.47002531 |
| 119 | ZAP70 | 0.45461693 |
| 120 | CAMK4 | 0.44647643 |
| 121 | SIK2 | 0.44631323 |
| 122 | TRPM7 | 0.44615267 |
| 123 | TNK2 | 0.43643589 |
| 124 | PTK2 | 0.43578722 |
| 125 | FER | 0.43559973 |
| 126 | PDK2 | 0.42897864 |
| 127 | ITK | 0.42674686 |
| 128 | RET | 0.42661922 |
| 129 | GRK7 | 0.42624504 |
| 130 | MARK3 | 0.42430032 |
| 131 | SYK | 0.40161153 |
| 132 | PRKAA1 | 0.40059644 |
| 133 | ROCK1 | 0.39732527 |
| 134 | MAPK11 | 0.39294978 |
| 135 | INSR | 0.39228778 |
| 136 | ARAF | 0.39198340 |
| 137 | OBSCN | 0.38752166 |
| 138 | PRKAA2 | 0.37960427 |
| 139 | BMX | 0.37732226 |
| 140 | ROCK2 | 0.37044379 |
| 141 | PAK2 | 0.36642343 |
| 142 | SRC | 0.36173685 |
| 143 | IRAK4 | 0.35967499 |
| 144 | PRKD3 | 0.35866267 |
| 145 | MATK | 0.34864428 |
| 146 | CDC42BPA | 0.33947837 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.62787635 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.97171875 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.95018870 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.82095651 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.70407517 |
| 6 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.57086866 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.50698417 |
| 8 | Viral myocarditis_Homo sapiens_hsa05416 | 2.46809664 |
| 9 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.28918472 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 2.27424813 |
| 11 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.24540183 |
| 12 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.07968593 |
| 13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.01227192 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.99365989 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.93101023 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.90857260 |
| 17 | Focal adhesion_Homo sapiens_hsa04510 | 1.86422703 |
| 18 | Sulfur relay system_Homo sapiens_hsa04122 | 1.81946688 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.79689463 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.77966168 |
| 21 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.70561141 |
| 22 | Lysosome_Homo sapiens_hsa04142 | 1.58844400 |
| 23 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.53736806 |
| 24 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.52278007 |
| 25 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.50290864 |
| 26 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.44187145 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.40261224 |
| 28 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.39830416 |
| 29 | Carbon metabolism_Homo sapiens_hsa01200 | 1.36618337 |
| 30 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.35216555 |
| 31 | Insulin resistance_Homo sapiens_hsa04931 | 1.34936468 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.31655038 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.28178832 |
| 34 | Lysine degradation_Homo sapiens_hsa00310 | 1.28177942 |
| 35 | Bladder cancer_Homo sapiens_hsa05219 | 1.25360504 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.22920290 |
| 37 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.22528857 |
| 38 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.22447397 |
| 39 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.22074853 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.18529709 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.18500842 |
| 42 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.18467429 |
| 43 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.18304609 |
| 44 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.16722633 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.16506794 |
| 46 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.14428493 |
| 47 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.13544121 |
| 48 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.12213916 |
| 49 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.10133135 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.09092132 |
| 51 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.08487587 |
| 52 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.06519666 |
| 53 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.05199273 |
| 54 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.05059494 |
| 55 | Tuberculosis_Homo sapiens_hsa05152 | 1.04835090 |
| 56 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.04594539 |
| 57 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.04024553 |
| 58 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.01243931 |
| 59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.99606677 |
| 60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.97474524 |
| 61 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.94774441 |
| 62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.94383064 |
| 63 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.93474334 |
| 64 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.93367748 |
| 65 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.92680732 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 0.91896518 |
| 67 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.90056861 |
| 68 | Platelet activation_Homo sapiens_hsa04611 | 0.89724131 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.88238371 |
| 70 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.87706015 |
| 71 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.87235645 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.87085900 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.86686769 |
| 74 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.85158781 |
| 75 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.84662322 |
| 76 | Hepatitis B_Homo sapiens_hsa05161 | 0.83762694 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.82879524 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77915898 |
| 79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.77717704 |
| 80 | Gap junction_Homo sapiens_hsa04540 | 0.77695903 |
| 81 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.77478883 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77259848 |
| 83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.75635803 |
| 84 | Amoebiasis_Homo sapiens_hsa05146 | 0.74554265 |
| 85 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.73862749 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72457919 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.72380204 |
| 88 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.70812355 |
| 89 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.70807488 |
| 90 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.70300167 |
| 91 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.69388565 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.69254676 |
| 93 | Apoptosis_Homo sapiens_hsa04210 | 0.69199902 |
| 94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.68474806 |
| 95 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.67924164 |
| 96 | Bile secretion_Homo sapiens_hsa04976 | 0.67876010 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67746470 |
| 98 | Pertussis_Homo sapiens_hsa05133 | 0.67149782 |
| 99 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.66563930 |
| 100 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66458510 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.66006870 |
| 102 | HTLV-I infection_Homo sapiens_hsa05166 | 0.65081604 |
| 103 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.64494496 |
| 104 | Salmonella infection_Homo sapiens_hsa05132 | 0.63240601 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.62823490 |
| 106 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.62659174 |
| 107 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62251991 |
| 108 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61212561 |
| 109 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.61023167 |
| 110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60931463 |
| 111 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.60018546 |
| 112 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.59364612 |
| 113 | Peroxisome_Homo sapiens_hsa04146 | 0.57322088 |
| 114 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57048773 |
| 115 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.55816141 |
| 116 | Prion diseases_Homo sapiens_hsa05020 | 0.55622453 |
| 117 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.54888634 |
| 118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54603968 |
| 119 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54592569 |
| 120 | Adherens junction_Homo sapiens_hsa04520 | 0.54055104 |
| 121 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53941135 |
| 122 | Phagosome_Homo sapiens_hsa04145 | 0.53866536 |
| 123 | Endocytosis_Homo sapiens_hsa04144 | 0.53721713 |
| 124 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52727654 |
| 125 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.52410480 |
| 126 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52218848 |
| 127 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51468871 |
| 128 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.50833650 |
| 129 | Thyroid cancer_Homo sapiens_hsa05216 | 0.50141562 |
| 130 | Leishmaniasis_Homo sapiens_hsa05140 | 0.48712117 |
| 131 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48001147 |
| 132 | Measles_Homo sapiens_hsa05162 | 0.46796676 |
| 133 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.46214398 |
| 134 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.44935842 |
| 135 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44285329 |
| 136 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.42980128 |
| 137 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.41833376 |
| 138 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41585679 |
| 139 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.39953975 |
| 140 | Pathways in cancer_Homo sapiens_hsa05200 | 0.38632343 |
| 141 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.37987811 |
| 142 | Tight junction_Homo sapiens_hsa04530 | 0.37431498 |
| 143 | Hepatitis C_Homo sapiens_hsa05160 | 0.37207385 |
| 144 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36557613 |
| 145 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.35968937 |
| 146 | Shigellosis_Homo sapiens_hsa05131 | 0.35326832 |
| 147 | Renin secretion_Homo sapiens_hsa04924 | 0.35282378 |
| 148 | Influenza A_Homo sapiens_hsa05164 | 0.34896561 |
| 149 | Glioma_Homo sapiens_hsa05214 | 0.34072590 |
| 150 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.32812352 |
| 151 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32217320 |
| 152 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31695415 |
| 153 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.31409048 |
| 154 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.30415367 |

